Trial Profile
Placebo-Controlled, Double-Blind, Ascending Single and Multiple Oral Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-791826 and to Assess Its Marker Specific Pharmacodynamics in Relation to Prednisolone in Healthy Males
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jun 2020
Price :
$35
*
At a glance
- Drugs BMS 791826 (Primary) ; Prednisolone
- Indications Immunological disorders
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 29 Jun 2017 New trial record